SLC37A4 and fatty liver disease: In the present study, apigenin also upregulated mRNA expression of hepatic Slc37a4 mRNA, whose expression was decreased during the progression of liver fibrosis [55], and suppression of this molecule was associated with stimulation of de novo lipogenesis and the development of hepatic steatosis [56].